Ameritas Advisory Services’s 10x Genomics TXG Stock Holding History

Ameritas Advisory Services’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20,000	Closed	-$389K	–	937
2024 Q2	$389K	Sell	20,000 -5,417	-21%	-$142K	0.01%	654
2024 Q1	$954K	Buy	+25,417	New	+$1.12M	0.04%	390
2023 Q4	–	Sell	-25,422	Closed	-$1.05M	–	841
2023 Q3	$1.05M	Buy	+25,422	New	+$1.32M	0.05%	330
2023 Q2	–	Sell	-25,426	Closed	-$1.38M	–	2372
2023 Q1	$1.38M	Sell	25,426 -3	-0%	-$140	0.07%	259
2022 Q4	$927K	Sell	25,429 -2	-0%	-$65	0.04%	371
2022 Q3	$724K	Buy	25,431 +11	+0%	+$419	0.04%	355
2022 Q2	$1.15M	Hold	25,420	–	–	0.07%	266
2022 Q1	$1.93M	Hold	25,420	–	–	0.07%	216
2021 Q4	$3.79M	Buy	+25,420	New	+$3.89M	0.14%	124

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Ameritas Advisory Services's TXG Position: Q3 2024 in Review

Ameritas Advisory Services sold out of 10x Genomics (TXG) in Q3 2024, closing a stake of 20,000 shares — an estimated $389K sold.

Ameritas Advisory Services first reported a position in TXG in Q4 2021 and held it in 9 quarters. The position peaked at $3.79M in Q4 2021. 266 funds tracked by Wall St. Rank hold TXG as of Q3 2024.

Ameritas Advisory Services reported no remaining 10x Genomics position as of Q3 2024 after selling out during the quarter.
Ameritas Advisory Services sold 20,000 10x Genomics shares in Q3 2024, an estimated $389K.
Ameritas Advisory Services first reported a position in 10x Genomics in Q4 2021 and held it in 9 quarters.
Ameritas Advisory Services's 10x Genomics position peaked at $3.79M in Q4 2021.
266 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2024.

Based on Ameritas Advisory Services's 13F filing for Q3 2024, filed 30 Oct 2024.